Page 27 - Ipca Laboratories News Today

Read more about Ipca Laboratories consolidated net profit rises 87.58% in the March 2021 quarter on Business Standard. Sales rise 3.81% to Rs 1114.66 crore

Ipca Labs Q4 profit up 94 pc at Rs 161 cr Ipca Labs Q4 profit up 94 pc at Rs 161 cr New Delhi, May 28: Drug firm Ipca Laboratories on Friday reported 94.09 per cent rise in consolidated net profit at Rs 161.20 crore for March quarter 2020-21 mainly on account of higher sales and reduction in expenses. The company posted a net profit of Rs 83.05 crore for the same period a year ago, Ipca Labs said in a filing to BSE. Total income stood at Rs 1,134.58 crore in the quarter under review. It was Rs...

Read more about Drug firm Ipca Laboratories fourth quarter profit up 94% at Rs 161 crore on Business Standard. Shares of Ipca Laboratories were trading at Rs 2,132.30 per scrip on BSE, down 3.06 per cent from the previous close.

Ipca Laboratories with a target price of Rs 2335. The current market price of Ipca Laboratories Ltd. is Rs 2220. Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 28015.29 Crore) operating in Pharmaceuticals sector. Financials For the quarter ended 31-12-2020, the company reported a Consolidated Total Income of Rs 1425.21 Crore, up 3.53 % from last quarter Total Income of Rs 1376.55 Crore and up 15.78 % from last year same quarter Total Inco...

Ahead of Market: 12 things that will decide stock action on Tuesday SECTIONS Last Updated: May 17, 2021, 10:06 PM IST Share Synopsis Nifty formed a healthy bullish candle on the daily scale even as it negated the formation of lower highs and lows of the last three sessions. Getty Images Manish Hathiramani, Proprietary Index Trader and Technical Analyst of Deen Dayal Investments, said the market may remain bullish as it has managed to zoom past the 14,850 level. Related NSE By Sabari Saran New...

: Saturday, May 1, 2021, 8:13 PM IST Stocks to beat Monday blues: Watch out for stocks of RIL, SBI General Insurance, Ipca Lab, HDFC Bank, SBI, IndusInd Bank, Shriram City Union Finance Stocks to beat Monday blues: Watch out for stocks of RIL, SBI General Insurance, Ipca Lab, HDFC Bank, SBI, IndusInd Bank, Shriram City Union Finance On Friday, many heavyweights like Reliance Industries, IndusInd Bank among others reported higher profits in the fourth quarter. So, when the market opens on Monda...

Investors make Rs 2.1 lakh crore as Sensex extends rally to third day on earnings boost SECTIONS Investors make Rs 2.1 lakh crore as Sensex extends rally to third day on earnings boostBy Share Synopsis A buying spree by domestic institutional investors and retail investors is also negating the impact of foreign fund outflows, say analysts. The NSE Nifty 50 index gained 211.50 points or 1.44% to end at 14,864.55. Related NSE Explore Now NEW DELHI: Equity benchmarks extended a rally to the third...

Mazhar Mohammad of Chartviewindia.in said that the index needs to sustain above the bullish gap of 14,695-667 registered in Wednesdays session.

Why the stock of Alkem Labs is a good ‘Buy’ The stock is suitable for long-term investors, given multiple positives and reasonable valuation Alkem Laboratories, the fifth largest pharma company in India, is a dominant player in acute therapy areas with well-established brands. The company is ranked number one — market share in terms of revenue — in anti-infectives. It also has the third largest market share each in gastro-intestinal and pain and analgesics therapies. Over the years, Alk...

Explore Now Mumbai: India’s stock benchmarks — Nifty and Sensex — are trading at record high valuations but there are pockets in the market where stocks are not as expensive as the main indices. Pharmaceutical, cement and select state-owned stocks are among the undervalued stocks within the BSE 500 universe going by their current Price to Earnings (PE) ratio — a popular valuation measure - vis-a-vis their 10-year averages, data compiled by ETIG Database showed. Analysts believe cyclical...